NGAM Advisors L.P. reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 11.7% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 61,405 shares of the company’s stock after selling 8,128 shares during the period. NGAM Advisors L.P.’s holdings in Cardinal Health were worth $4,785,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of CAH. Chevy Chase Trust Holdings Inc. boosted its position in Cardinal Health by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 274,051 shares of the company’s stock valued at $22,349,000 after buying an additional 4,174 shares during the last quarter. Charter Trust Co. boosted its position in Cardinal Health by 107.4% in the first quarter. Charter Trust Co. now owns 6,330 shares of the company’s stock valued at $516,000 after buying an additional 3,278 shares during the last quarter. Sheets Smith Wealth Management boosted its position in Cardinal Health by 7.4% in the first quarter. Sheets Smith Wealth Management now owns 36,500 shares of the company’s stock valued at $2,977,000 after buying an additional 2,500 shares during the last quarter. Gulf International Bank UK Ltd boosted its position in Cardinal Health by 1.3% in the first quarter. Gulf International Bank UK Ltd now owns 98,741 shares of the company’s stock valued at $8,052,000 after buying an additional 1,300 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its position in Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares during the last quarter. Institutional investors and hedge funds own 87.09% of the company’s stock.

Shares of Cardinal Health, Inc. (CAH) opened at 69.14 on Monday. The company has a market cap of $21.85 billion, a price-to-earnings ratio of 17.16 and a beta of 0.80. The stock has a 50 day moving average of $77.38 and a 200 day moving average of $77.27. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $84.90.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. Cardinal Health’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 earnings per share. On average, equities analysts expect that Cardinal Health, Inc. will post $5.07 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “NGAM Advisors L.P. Has $4.79 Million Stake in Cardinal Health, Inc. (NYSE:CAH)” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/07/ngam-advisors-l-p-has-4-79-million-stake-in-cardinal-health-inc-nysecah.html.

CAH has been the subject of several research analyst reports. William Blair cut shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Leerink Swann set a $72.00 target price on shares of Cardinal Health and gave the company a “hold” rating in a research note on Friday, April 21st. Barclays PLC reiterated an “overweight” rating and set a $82.00 target price (down from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. Cowen and Company cut their target price on shares of Cardinal Health from $89.00 to $82.00 and set a “market perform” rating for the company in a research note on Tuesday, April 25th. Finally, Zacks Investment Research cut shares of Cardinal Health from a “hold” rating to a “sell” rating in a research note on Friday, April 28th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. Cardinal Health currently has an average rating of “Hold” and a consensus target price of $80.46.

In related news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the business’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $72.87, for a total value of $1,695,684.90. Following the completion of the transaction, the insider now owns 55,440 shares of the company’s stock, valued at $4,039,912.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.94% of the stock is owned by insiders.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.